Clinical role of MMP‐2/TIMP‐2 imbalance in hepatocellular carcinoma

International Journal of Cancer - Tập 97 Số 4 - Trang 425-431 - 2002
Gianluigi Giannelli1, Carlo Bergamini1, Felice Marinosci1, Emilia Fransvea1, Michele Quaranta2, L. Lupo3, O Schiraldi1, Salvatore Antonaci1
1Department of Internal Medicine, Immunology and Infectious Diseases, Section of Internal Medicine, University of Bari Medical School, Bari, Italy
2Laboratory of Clinical Diagnostic, Oncology Institute, Bari, Italy
3Department of Emergency and Organ Transplantation, University of Bari Medical School, Bari, Italy

Tóm tắt

AbstractAn imbalance between the proteolytic activity of matrix metalloproteinase‐2 (MMP‐2) and the tissue inhibitor of MMP‐2 (TIMP‐2) is responsible for degradation of extracellular matrix (ECM) components and plays a critical role in tumor invasion and in metastasis formation. The occurrence of intra‐hepatic metastasis, which severely affects prognosis and long‐term survival, is commonly observed in the course of hepatocellular carcinoma (HCC). We investigated the expression of MT1‐MMP in tissues, whereas both MMP‐2 and TIMP‐2 were evaluated in the sera and tissues (primary and metastatic nodules) of HCC patients with and without metastasis, whose clinical outcome was followed over a 2‐year period. MT1‐MMP expression was similar among primary nodule tissues of patients with and without metastasis. Serum and tissue levels of MMP‐2 were not statistically different between patients with and without metastasis, but MMP‐2 was concentrated at the invasive edge of the metastatic tissue. On the contrary, serum and tissue levels of TIMP‐2 were significantly higher in HCC patients without metastasis than in those with. This situation was not only observed in the primary HCC tissues, but also in the metastatic nodules. These results correlate with the clinical outcome, because more than 90% of the patients with high levels of TIMP‐2 were still alive after 2 years, whereas less than 30% with low levels of TIMP‐2 had survived. Furthermore, we found a strict correlation between tissue and serum levels of TIMP‐2, this suggesting that a MMP‐2/TIMP‐2 imbalance and in particular TIMP‐2 levels, could represent an important prognostic factor in patients with HCC. © 2001 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

Nagase H, 1997, Activation mechanisms of matrix metalloproteinases, Biol Chem, 378, 151

10.1074/jbc.270.10.5331

10.1038/284067a0

10.1016/S1074-5521(96)90178-7

10.1016/0955-0674(92)90103-J

10.1126/science.277.5323.225

10.1023/A:1006797522521

10.1016/S0167-4838(99)00279-4

10.1016/S0190-9622(87)70293-X

10.1002/ijc.2910630504

10.1016/S0092-8674(00)80429-8

10.1016/S0002-9440(10)65371-0

10.1007/s002800051097

10.1016/S0955-0674(99)00026-5

10.1016/S0955-0674(99)00022-8

Kohn EC, 1995, Molecular insights into cancer invasion: strategies for prevention and intervention, Cancer Res, 55, 1856

Grigioni WF, 1994, Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane, Mod Pathol, 7, 220

10.1146/annurev.cb.09.110193.002545

10.1097/00001622-200007000-00013

10.1016/0016-5085(94)90707-2

10.1038/labinvest.3780270

Bu W, 1998, Effects of matrix metalloproteinase inhibitor BB‐94 on liver cancer growth and metastasis in a patient‐like orthotopic model LCI‐D20, Hepatogastroenterology, 45, 1056

10.1002/hep.510300432

10.1053/gast.1996.v110.pm8608892

Eggel H, 1901, Uber das primare carcinom der leber, Beitr Pathol Anat, 30, 506

10.1016/0955-0674(95)80116-2

10.1083/jcb.148.3.615

10.1016/S0016-5085(97)70143-4

10.1016/S0046-8177(99)90121-1

10.1002/hep.510230608

10.1016/S0140-6736(89)91016-7

DeClerck YA, 1992, Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases, Cancer Res, 52, 701

10.1093/jnci/83.11.775

10.1007/978-3-642-58456-5_20

10.1016/S0092-8674(00)81235-0

10.1016/S0168-8278(97)80425-4

Brand K, 2000, Treatment of colorectal liver metastasis by adenoviral transfer of tissue inhibitor of metalloproteinases‐2 into the liver tissue, Cancer Res, 60, 5723

Thông tin
Thông tin xuất bản

International Journal of Cancer

Tập 97 Số 4

425-431

Thông tin tác giả